trimipramine 25mg tablets
medihealth (northern) ltd - trimipramine maleate - oral tablet - 25mg
trimipramine 50mg capsules
medihealth (northern) ltd - trimipramine maleate - oral capsule - 50mg
trimipramine 50mg capsules
glenmark pharmaceuticals europe ltd - trimipramine maleate - oral capsule - 50mg
trimipramine 50mg capsules
teva uk ltd - trimipramine maleate - oral capsule - 50mg
surmontil 50mg hard capsules
sanofi-aventis ireland limited t/a sanofi - trimipramine maleate - capsule, hard - 50 milligram(s) - non-selective monoamine reuptake inhibitors; trimipramine
surmontil 50mg hard capsules
neuraxpharm ireland limited - trimipramine maleate - capsule, hard - non-selective monoamine reuptake inhibitors; trimipramine
surmontil 50mg capsules
sigma pharmaceuticals plc - trimipramine maleate - oral capsule - 50mg
surmontil
pharmacy retailing (nz) ltd t/a healthcare logistics - trimipramine maleate 69.75mg equivalent to 50 mg trimipramine base; - capsule - 50 mg - active: trimipramine maleate 69.75mg equivalent to 50 mg trimipramine base excipient: colloidal silicon dioxide indigo carmine iron oxide yellow magnesium stearate maize starch microcrystalline cellulose titanium dioxide - indicated in the treatment of depressive illness, especially where sleep disturbance, anxiety or agitation is a presenting symptom. sleep disturbance is controlled within 24 hours and true anti-depressant action follows within 7-10 days.
surmontil 25mg film-coated tablets
sanofi-aventis ireland limited t/a sanofi - trimipramine - film-coated tablet - 25 milligram(s) - non-selective monoamine reuptake inhibitors; trimipramine
surmontil 25mg film-coated tablets
neuraxpharm ireland limited - trimipramine - film-coated tablet - non-selective monoamine reuptake inhibitors; trimipramine